Research Summary
Peptide API CDMO (Contract Development and Manufacturing Organization) services involve the synthesis, development, and production of peptide Active Pharmaceutical Ingredients (APIs) for pharmaceutical companies. These services encompass the entire process of peptide drug development, from initial research and design to commercial-scale manufacturing. CDMOs specializing in peptide APIs offer expertise in peptide chemistry, process optimization, analytical methods development, and regulatory compliance. They assist pharmaceutical companies in custom synthesis of peptides, process scale-up, formulation development, and manufacturing of high-quality peptide APIs for clinical trials and commercialization. Peptide API CDMO services provide pharmaceutical companies with the flexibility, efficiency, and expertise needed to accelerate drug development timelines and bring peptide-based therapeutics to market.
According to DIResearch's in-depth investigation and research, the global Peptide API CDMO Services market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Peptide API CDMO Services include Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermofischer, Bio Basic, JPT, Genscript, Xinbang Pharma, ScinoPharm, SN Biopharm, CBL, Piramal Pharma, CPC Scientific etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Peptide API CDMO Services. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Peptide API CDMO Services market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Peptide API CDMO Services market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Peptide API CDMO Services industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Peptide API CDMO Services Include:
Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CPC Scientific
Peptide API CDMO Services Product Segment Include:
GMP Services
Non-GMP Services
Peptide API CDMO Services Product Application Include:
Commercial
Scientific Research
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Peptide API CDMO Services Industry PESTEL Analysis
Chapter 3: Global Peptide API CDMO Services Industry Porter’s Five Forces Analysis
Chapter 4: Global Peptide API CDMO Services Major Regional Market Size and Forecast Analysis
Chapter 5: Global Peptide API CDMO Services Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Peptide API CDMO Services Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Peptide API CDMO Services Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Peptide API CDMO Services Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Peptide API CDMO Services Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Peptide API CDMO Services Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Peptide API CDMO Services Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Peptide API CDMO Services Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Peptide API CDMO Services Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Peptide API CDMO Services Product by Type
- 1.2.1 GMP Services
- 1.2.2 Non-GMP Services
- 1.3 Peptide API CDMO Services Product by Application
- 1.3.1 Commercial
- 1.3.2 Scientific Research
- 1.3.3 Other
- 1.4 Global Peptide API CDMO Services Market Size Analysis (2020-2032)
- 1.5 Peptide API CDMO Services Market Development Status and Trends
- 1.5.1 Peptide API CDMO Services Industry Development Status Analysis
- 1.5.2 Peptide API CDMO Services Industry Development Trends Analysis
- 2 Peptide API CDMO Services Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Peptide API CDMO Services Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Peptide API CDMO Services Market Analysis by Regions
- 4.1 Global Peptide API CDMO Services Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Peptide API CDMO Services Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Peptide API CDMO Services Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Peptide API CDMO Services Revenue Forecast by Region (2026-2032)
- 5 Global Peptide API CDMO Services Market Size by Type and Application
- 5.1 Global Peptide API CDMO Services Market Size by Type (2020-2032)
- 5.2 Global Peptide API CDMO Services Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Peptide API CDMO Services Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Peptide API CDMO Services Market Size by Type
- 6.4 North America Peptide API CDMO Services Market Size by Application
- 6.5 North America Peptide API CDMO Services Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Peptide API CDMO Services Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Peptide API CDMO Services Market Size by Type
- 7.4 Europe Peptide API CDMO Services Market Size by Application
- 7.5 Europe Peptide API CDMO Services Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Peptide API CDMO Services Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Peptide API CDMO Services Market Size by Type
- 8.4 China Peptide API CDMO Services Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Peptide API CDMO Services Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Peptide API CDMO Services Market Size by Type
- 9.4 APAC (excl. China) Peptide API CDMO Services Market Size by Application
- 9.5 APAC (excl. China) Peptide API CDMO Services Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Peptide API CDMO Services Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Peptide API CDMO Services Market Size by Type
- 10.4 Latin America Peptide API CDMO Services Market Size by Application
- 10.5 Latin America Peptide API CDMO Services Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Peptide API CDMO Services Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Peptide API CDMO Services Market Size by Type
- 11.4 Middle East & Africa Peptide API CDMO Services Market Size by Application
- 11.5 Middle East & Africa Peptide API CDMO Services Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Peptide API CDMO Services Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Peptide API CDMO Services Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Peptide API CDMO Services Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Bachem
- 13.1.1 Bachem Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Bachem Peptide API CDMO Services Product Portfolio
- 13.1.3 Bachem Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 PolyPeptide
- 13.2.1 PolyPeptide Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 PolyPeptide Peptide API CDMO Services Product Portfolio
- 13.2.3 PolyPeptide Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 CordenPharma
- 13.3.1 CordenPharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 CordenPharma Peptide API CDMO Services Product Portfolio
- 13.3.3 CordenPharma Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 AmbioPharm
- 13.4.1 AmbioPharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 AmbioPharm Peptide API CDMO Services Product Portfolio
- 13.4.3 AmbioPharm Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 USV Peptides
- 13.5.1 USV Peptides Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 USV Peptides Peptide API CDMO Services Product Portfolio
- 13.5.3 USV Peptides Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Thermofischer
- 13.6.1 Thermofischer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Thermofischer Peptide API CDMO Services Product Portfolio
- 13.6.3 Thermofischer Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Bio Basic
- 13.7.1 Bio Basic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Bio Basic Peptide API CDMO Services Product Portfolio
- 13.7.3 Bio Basic Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 JPT
- 13.8.1 JPT Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 JPT Peptide API CDMO Services Product Portfolio
- 13.8.3 JPT Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Genscript
- 13.9.1 Genscript Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Genscript Peptide API CDMO Services Product Portfolio
- 13.9.3 Genscript Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Xinbang Pharma
- 13.10.1 Xinbang Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Xinbang Pharma Peptide API CDMO Services Product Portfolio
- 13.10.3 Xinbang Pharma Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 ScinoPharm
- 13.11.1 ScinoPharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 ScinoPharm Peptide API CDMO Services Product Portfolio
- 13.11.3 ScinoPharm Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.12 SN Biopharm
- 13.12.1 SN Biopharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 SN Biopharm Peptide API CDMO Services Product Portfolio
- 13.12.3 SN Biopharm Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.13 CBL
- 13.13.1 CBL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 CBL Peptide API CDMO Services Product Portfolio
- 13.13.3 CBL Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.14 Piramal Pharma
- 13.14.1 Piramal Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Piramal Pharma Peptide API CDMO Services Product Portfolio
- 13.14.3 Piramal Pharma Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.15 CPC Scientific
- 13.15.1 CPC Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 CPC Scientific Peptide API CDMO Services Product Portfolio
- 13.15.3 CPC Scientific Peptide API CDMO Services Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Peptide API CDMO Services Industry Chain Analysis
- 14.2 Peptide API CDMO Services Industry Raw Material and Suppliers Analysis
- 14.2.1 Peptide API CDMO Services Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Peptide API CDMO Services Typical Downstream Customers
- 14.4 Peptide API CDMO Services Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook